*EMBARGOED All research presented at the 2023 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 22, 2023, at 3:00 pm PT.
P3382 – Improvements in Psychological Outcomes Following App-Delivered Gut-Directed Hypnotherapy: Highlighting the Importance of the Biopsychosocial Model of Care in IBS
Tuesday, October 24, 2023 | 10:30 AM – 4:00 PM PT | Location: Exhibit Hall
Author Insight from Simone Peters, PhD, Monash University, Melbourne, Victoria, Australia
What’s new here and important for clinicians?
- App-delivered gut-directed hypnotherapy is an effective way of managing physical symptoms in patients with IBS
- 40% and 30% of IBS patients respectively will have anxiety and depression
- In the majority the gastrointestinal symptoms develop before the onset of the mood disorder
- Rates of efficacy in digitally delivered therapeutics are similar to those in face-to-face settings
- Delivering GDH digitally allows for greater access to appropriately qualified professionals
- App-delivered GDH provides a cost-effective way to access a therapy that might otherwise be unattainable
What do patients need to know?
- App-delivered gut-directed hypnotherapy program Nerva is effective in helping patients manage both the physical and psychological symptoms associated with IBS (established in RCT and retrospective analyses)
- Nerva can be downloaded from the App Store (Apple and Android)
- It is a 6-week program consisting of hypnotherapy, psychoeducation and breathing exercises
- Digital therapeutics offer an accessible and affordable management strategy for IBS populations
Read the Abstract
Simone Peters, PhD, Monash University, Melbourne, Victoria, Australia
simone.peters [at] monash.edu
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.